Advertisement
Screener

Vir Biotechnology, Inc. (VIR) ROA

Vir Biotechnology, Inc. (VIR) ROA

  • 2026-06-30: ROA -20.72%.
  • 2026-03-31: ROA -43.17%.
  • 2025-12-31: ROA -43.68%.
  • 2025-09-30: ROA -49.01%.

Complete source-backed roa history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-20.72%
2026-03-31-43.17%
2025-12-31-43.68%
2025-09-30-49.01%
2025-06-30-46.14%
2025-03-31-44.17%
2024-12-31-37.31%
2024-09-30-35.60%
2024-06-30-28.93%
2024-03-31-30.07%
2023-12-31-32.05%
2023-09-30-29.38%
2023-06-30-11.68%
2023-03-31-5.39%
2022-12-3118.41%
2022-09-3042.39%
2022-06-3041.15%
2022-03-3142.12%
2021-12-3127.05%
2021-09-30-8.45%
2021-06-30-28.12%
2021-03-31-34.37%
2020-12-31-32.51%
2020-09-30-27.22%
2020-06-30-32.80%
2020-03-31-46.79%
2019-12-31-34.11%
2019-09-30-32.49%

Annual ROA

DateROA
2025-12-31-43.68%
2024-12-31-37.31%
2023-12-31-32.05%
2022-12-3118.41%
2021-12-3127.05%
2020-12-31-32.51%
2019-12-31-34.11%
2018-12-31-60.48%

Similar stocks

Stock NameCountryMarket CapPE Ratio
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Vericel Corp (VCEL)United States$2.011B93.97
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40